Charlotte Brasch‐Andersen
- Molecular Biology
- Oncology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Genetics top 10%
- Pharmacology top 2%
- Co-authors
- Kim BrøsenPer DamkierHenrik GréenFlemming NielsenMette Marie Hougaard ChristensenHenning Beck‐NielsenTorben A. KruseTroels K. Bergmann
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Genomic variations and chromosomal abnormalities (7 papers)Glutathione Transferases and Polymorphisms (6 papers)
In The Last Decade
Charlotte Brasch‐Andersen
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 497
- Oncology 302
- Endocrinology, Diabetes and Metabolism 201
- Genetics 198
- Pharmacology 177
Countries citing papers authored by Charlotte Brasch‐Andersen
This map shows the geographic impact of Charlotte Brasch‐Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Brasch‐Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Brasch‐Andersen more than expected).
Fields of papers citing papers by Charlotte Brasch‐Andersen
This network shows the impact of papers produced by Charlotte Brasch‐Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Brasch‐Andersen. The network helps show where Charlotte Brasch‐Andersen may publish in the future.
Co-authorship network of co-authors of Charlotte Brasch‐Andersen
This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Brasch‐Andersen. A scholar is included among the top collaborators of Charlotte Brasch‐Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Brasch‐Andersen. Charlotte Brasch‐Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 12 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 9 | |
| 13 | 3 | |
| 14 | 6 | |
| 15 | 3 | |
| 16 | 28 | |
| 17 | 78 | |
| 18 | 4 | |
| 19 | 12 | |
| 20 | 32 |
About Charlotte Brasch‐Andersen
Charlotte Brasch‐Andersen is a scholar working on Pharmacology, Genetics and Developmental Biology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Genomic variations and chromosomal abnormalities (7 papers) and Glutathione Transferases and Polymorphisms (6 papers). The work is most often cited by research in Pharmacology (177 citations), Endocrinology, Diabetes and Metabolism (201 citations) and Oncology (302 citations). Charlotte Brasch‐Andersen has collaborated with scholars based in Denmark, Sweden and Germany. Frequent co-authors include Kim Brøsen, Per Damkier, Henrik Gréen, Flemming Nielsen, Mette Marie Hougaard Christensen, Henning Beck‐Nielsen, Torben A. Kruse, Troels K. Bergmann, Lene Christiansen and Rasmus S. Pedersen. Their work appears in journals such as Nature Communications, Scientific Reports and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.